Walid Macaron, MD, MSc^1,2*, Elias Jabbour, MD², Nitin Jain, MD², Fadi G. Haddad, MD², Jayastu Senapati, MD, DM, MBBS², Partow Kebriaei, MD³, Eitan Kugler, MD PhD^2*, Kelly S. Chien, MD⁴, Ghayas C. Issa, MD², Jairo Matthews, BA^5*, Rebecca Garris^2*, Farhad Ravandi, MBBS⁶, Hagop M. Kantarjian, MD² and Nicholas J. Short, MD²

¹Department of Medicine, Baylor College of Medicine, Houston, TX
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, MD Anderson, Houston, TX
⁵The University of Texas at MD Anderson Cancer center, Houston, TX
⁶Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX

Roberta Santos Azevedo^1*, Hagop M. Kantarjian, MD¹, Koichi Takahashi, MD, PhD¹, Cedric Christophe Nasnas, MD^1*, Sanam Loghavi, MD², Nitin Jain, MD¹, Fadi G. Haddad, MD¹, Jayastu Senapati, MD, DM, MBBS¹, Ghayas C. Issa, MD¹, Hussein A. Abbas, MD, PhD¹, Tapan M. Kadia, MD¹, Kelly S. Chien, MD¹, Guillermo Montalban-Bravo, MD¹, Rebecca Garris^1*, Farhad Ravandi, MBBS¹, Elias Jabbour, MD³ and Nicholas J. Short, MD¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX

Ibrahim Aldoss, MD¹, Jeffrey Li^2*, Jianying Zhang, PhD^3*, Mary C Clark, PhD^4*, Vaibhav Agrawal, M.D.¹, Hoda Pourhassan, MD¹, Paul B. Koller, MD¹, Ahmed Aribi, MD^5*, Haris Ali, MD⁶, Amanda Blackmon, DO, MS^7*, Salman Otoukesh, MD⁶, Karamjeet S Sandhu, MD¹, Brian J. Ball, MD¹, Andrew Artz, MD, MS⁸, Idoroenyi Amanam, MD⁶, MHD Monzr M. Al Malki, MD¹, Amandeep Salhotra, MD⁶, Lindsey A. Murphy, MD², Dat Ngo, PharmD^9*, Jose Tinajero^2*, Zhaohui Gu, PhD², Pamela S. Becker, MD, PhD¹⁰, Ryotaro Nakamura, MD⁶, Anthony S. Stein, MD¹, Guido Marcucci¹¹, Stephen J. Forman, MD, FACP¹² and Vinod Pullarkat, MD¹²

¹Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
²City of Hope, Duarte, CA
³Beckman Research Institute, Duarte, CA
⁴Department of Clinical and Translational Project Development, City of Hope, Duarte, CA
⁵Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
⁶Hematology and HCT, City of Hope National Medical Center, Duarte, CA
⁷Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
⁸City of Hope National Medical Center, Duarte, CA
⁹Pharmacy, City of Hope National Medical Center, DUARTE, CA
¹⁰Hematology/HCT, City of Hope, Duarte, CA
¹¹Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, City of Hope Medical Center and Beckman Research Institute, Duarte, CA
¹²Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA

Gunnar Cario, MD^1*, Maria Grazia Valsecchi, PhD^2*, Valentino Conter, MD^3*, Giacomo Gotti, MD^4*, Anja Möricke, MD^1*, Martin Stanulla, MD^5*, Michaela Vossen-Gajcy^1*, Lennart Lenk, PhD^6*, Jan Stary, MD, DSc^7*, Michael Dworzak, MD^8*, Andishe Attarbaschi, MD^9,10*, Draga Barbaric, MD^11*, Franco Locatelli, MD¹², Nicole Bodmer, MD^13*, Sarah Elitzur, MD¹⁴, Daniela Silvestri^3*, Luciano Dalla-Pozza, MD¹⁵, Andreas E. Kulozik, MD, PhD¹⁶, Shai Izraeli, MD^17,18, Carmelo Rizzari, MD, PhD^4*, Barbara Buldini, MD, PhD¹⁹, Jean-Pierre Bourquin, MD, PhD²⁰, Francesca Graziano^21*, Martin Zimmermann, PhD^22*, Martin Schrappe, MD¹ and Andrea Biondi⁴

¹Department of Pediatrics I, Pediatric Hematology and Oncology, ALL-BFM Study Group, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany
²School of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy
³Tettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
⁴Pediatrics, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
⁵Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany
⁶Department of Pediatrics I, Pediatric Hematology and Oncology, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany, Kiel, Germany
⁷Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
⁸Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, St. Anna Children's Hospital, Vienna, Austria
⁹Department of Pediatric Hematology and Oncology, St. Anna Kinderspital, Vienna, Austria
¹⁰St. Anna Children´s Cancer Research Institute (CCRI), Vienna, Austria
¹¹Centre for Children's Cancer and Blood Disorders, Sydney Children's Hospital, Randwick NSW, AUS
¹²Department of Hematology-Oncology and Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy
¹³Department of Oncology, University Children's Hospital Zurich, Zurich, Switzerland
¹⁴Schneider Children's Medical Center, Petah Tikva, Israel
¹⁵Cancer Center for Children, Sydney, Australia
¹⁶Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University, Heidelberg, Germany
¹⁷The Dora and Gregorio Chair of Hematological Malignancies Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
¹⁸Department of Pediatric Hematology and Oncology, Schneider Children's Medical Center and Tel Aviv University, Petah Tikva, Israel
¹⁹University of Padova, Padua, Italy
²⁰Department of Pediatric Oncology, University Children's Hospital Zurich, Zurich, Switzerland
²¹Biostatistics and Clinical Epidemiology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
²²Department of Pediatric Hematology and Oncology, Medical School Hannover, Hannover, Germany

Nicolas Boissel, MD, PhD¹, Emilie Lemasle, MD^2*, Sylvain Chantepie, MD^3*, Thibaut Leguay, MD^4*, Corentin Orvain^5*, Françoise Huguet, MD^6*, Yosr Hicheri, MD^7*, Nathalie Dhédin, MD^8*, Patrice Chevallier, MD, PhD⁹, Marie Balsat, MD^10*, Sébastien Maury, MD, PhD^11*, Hunault-Berger Mathilde^12*, Karin Bilger^13*, Eolia Brissot¹⁴, Sebastian Wittnebel^15*, Julie Guerder^16*, Sarah Bonnet, MD^17*, Pascal Turlure, MD^18*, Anne Huynh, MD^19*, Claire Bories, MD^20*, Michael Gregor, MD^21*, Natacha Mauz^22*, Ahmad Aljijakli, MD^23*, Carlos Graux^24*, Yves Chalandon²⁵, Norbert Ifrah, MD, PhD²⁶, Vahid Asnafi, MD, PhD^27*, Emmanuelle Clappier, Pharm.D., Ph.D.^28*, Véronique Lheritier^29* and Hervé Dombret, MD^30*

¹Department of Hematology, Saint Louis University Hospital, AP-HP, Paris, France
²Hematology Department, Centre Henri Becquerel, Rouen, France
³Basse-Normandie Institute of Hematology, CHU de Caen, Caen, France
⁴Hematology, CHU Bordeaux, Hôpital du Haut-Lévêque, Pessac, France
⁵Hematology Clinic, Angers University Hospital, Angers, France
⁶Hematology Department, Institut Universitaire du Cancer-Oncopole & CHU de Toulouse, Toulouse, France
⁷Department of Hematology, Institut Paoli-Calmettes, Marseille, France
⁸Service d'Hématologie Adolescents et Jeunes Adultes, Hôpital Saint-Louis, PARIS, France
⁹Hematology Department, Nantes University Hospital, Nantes, France
¹⁰Clinical Hematology Department, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France, Lyon, France
¹¹Hematology Department, Henri Mondor University Hospital, UPEC, IMRB, Assistance Publique Hopitaux de Paris, Créteil, France
¹²Angers University Hospital, Angers, ML, France
¹³HOPITAL HAUTEPIERRE, STRASBOURG, FRA
¹⁴Sorbonne Université Service d' Hématologie Clinique et Thérapie Cellulaire, Hospital Saint-Antoine, Centre de Recherche Saint-Antoine (CRSA), Paris, France
¹⁵Jules Bordet Institute (HUB/ULB), Brussels, Belgium
¹⁶Service d'Hématologie Clinique, CHU de Dijon Bourgogne, DIJON, France
¹⁷Clinical Hematology Department, Montpellier University Hospital, Montpellier, France, montpellier, France
¹⁸Service d'Hématologie Clinique, CHU de Limoges, Limoges, France
¹⁹Hematology Department, Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France
²⁰Service d'Hématologie, CH de Lens, Lens, FRA
²¹Division of Hematology, Cantonal Hospital of Lucerne, Lucerne, Switzerland, Lucerne, Switzerland
²²Département d'Hématologie, Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy, France
²³CH Argenteuil, Argenteuil, France
²⁴CHU UCL Namur - site Godinne, Yvoir, Belgium
²⁵Division of Oncology and Hematology, Univ. Hospital of Geneva, Geneva, Switzerland
²⁶Hematology Department, CHU Angers, Angers, France
²⁷Laboratory of Onco-Hematology, Necker Enfants-Malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France
²⁸Saint Louis Hospital, Paris, France
²⁹Service d’Hématologie Coordination GRAALL, HCL, Hôpital Lyon Sud, Pierre Bénite, France
³⁰Hôpital Saint-Louis, Hematology Department, AP-HP, Paris, France

Daniel J. DeAngelo, MD, PhD¹, Ying Chen^2*, Ryan D. Cassaday, MD³, Jennifer Hibma, PharmD^4*, Derek Z Yang, Pharm D^4*, May Garrett^4*, Fan Zhang^5*, Svetoslav H Dimitrov, MD^6*, Erik Vandendries⁷ and Hagop M. Kantarjian, MD⁸

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Pfizer, San Diego, CA
³University of Washington and Fred Hutchinson Cancer Center, Seattle, WA
⁴Pfizer, San Diego
⁵Pfizer, Shanghai, China
⁶Pfizer, New York
⁷Pfizer Inc, Cambridge, MA
⁸Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX